Hikma Pharmaceuticals
HIK.L
A$40.78
Share price
-0.60%
Change (1 day)
8.25%
Change (1 year)
Categories
Revenue for Hikma Pharmaceuticals (HIK.L)
Revenue in 2024: A$4.79 Billion
According to Hikma Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is A$4.79 Billion. In 2024 the company made a revenue of A$4.79 Billion an increase over the revenue in the year 2023 that were of A$4.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hikma Pharmaceuticals from 2002 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | A$4.79 B | 8.77% |
| 2023 | A$4.40 B | 14.22% |
| 2022 | A$3.85 B | -1.41% |
| 2021 | A$3.91 B | 9.06% |
| 2020 | A$3.58 B | 6.07% |
| 2019 | A$3.38 B | 6.62% |
| 2018 | A$3.17 B | 6.92% |
| 2017 | A$2.96 B | -0.72% |
| 2016 | A$2.98 B | 35.42% |
| 2015 | A$2.20 B | -3.29% |
| 2014 | A$2.28 B | 9.08% |
| 2013 | A$2.09 B | 23.08% |
| 2012 | A$1.69 B | 20.8% |
| 2011 | A$1.40 B | 25.6% |
| 2010 | A$1.12 B | 14.77% |
| 2009 | A$0.97 B | 9.68% |
| 2008 | A$0.88 B | 29.38% |
| 2007 | A$0.68 B | 41.57% |
| 2006 | A$0.48 B | 20.9% |
| 2005 | A$0.40 B | 23.47% |
| 2004 | A$0.32 B | 101.98% |
| 2003 | A$0.16 B | 22.98% |
| 2002 | A$0.13 B |